Disclaimer
Last updated: 28 May 2026
IMPORTANT: The BioPharma Intelligence Hub is an informational data aggregation platform. It does NOT provide investment advice, financial advice, or medical advice. Nothing on this platform constitutes a recommendation to buy, sell, or hold any security.
1. Not Investment Advice
The information provided on the BioPharma Intelligence Hub ("Platform"), operated by MarketsHost, a private limited company registered in Chennai, Tamil Nadu, India, is for general informational and educational purposes only. The content on this Platform does not constitute, and should not be construed as, investment advice, financial advice, trading advice, or any other form of professional advice.
No information on this Platform should be interpreted as a recommendation or solicitation to buy, sell, hold, or otherwise transact in any security, financial instrument, or investment product. Users should not rely on any content on this Platform as the basis for any investment decision.
2. Pipeline Grades Are Analytical Assessments
The pipeline grades (A+, A, B, C, D) displayed on this Platform are analytical assessments of drug development progress and regulatory milestones. They are calculated using a transparent, rules-based methodology described in our Editorial Policy. These grades:
- Are NOT investment ratings, stock ratings, or buy/sell/hold recommendations
- Are NOT comparable to analyst ratings issued by financial institutions
- Do NOT predict stock price movement, investment returns, or FDA outcomes
- Reflect only the publicly available regulatory and clinical data at a point in time
- May change without notice as new data becomes available
3. No Buy, Sell, or Hold Recommendations
This Platform expressly does not make any buy, sell, or hold recommendations regarding any security or financial instrument. Any reference to specific companies, tickers, or securities is solely for informational purposes to identify the companies whose drug pipelines are being analyzed. Mention of a company or security does not constitute an endorsement or recommendation of any kind.
4. Past Regulatory Outcomes Do Not Predict Future FDA Decisions
Historical FDA approval rates, past regulatory decisions, and prior clinical trial outcomes presented on this Platform are provided for informational context only. Past regulatory outcomes do not guarantee, indicate, or predict future FDA decisions. Each drug application is evaluated independently by the FDA based on its own merits, safety profile, and efficacy data. Users should not rely on historical approval patterns to forecast the outcome of any pending or future regulatory action.
5. AI-Generated Content May Contain Errors
Certain content on this Platform, including company summaries, pipeline analyses, and data interpretations, is generated or assisted by artificial intelligence (Google Gemini). All AI-generated content is clearly labeled. While we strive for accuracy, AI-generated content:
- May contain factual errors, inaccuracies, or outdated information
- May misinterpret, oversimplify, or omit material information
- Should not be relied upon as the sole source of information for any purpose
- Is provided "as is" without warranty of accuracy or completeness
Users are strongly encouraged to verify all AI-generated content against the linked primary sources before relying on it for any purpose.
6. Data Sources
The data presented on this Platform is aggregated from publicly available U.S. government sources, including but not limited to:
- U.S. Food and Drug Administration (FDA) -- Public domain regulatory data
- U.S. Securities and Exchange Commission (SEC EDGAR) -- Public company filings
- ClinicalTrials.gov -- Clinical trial registry data (National Library of Medicine)
- DailyMed (National Institutes of Health) -- Drug labeling information
While these sources are generally reliable, MarketsHost does not warrant the accuracy, completeness, timeliness, or reliability of any data obtained from third-party sources. Data may be subject to delays, errors in transmission, or differences between our aggregated presentation and the original source.
7. Regulatory Status
MarketsHost, the operator of the BioPharma Intelligence Hub:
- Is NOT registered with the Securities and Exchange Board of India (SEBI) as an investment advisor, research analyst, or in any other capacity
- Is NOT registered with the U.S. Securities and Exchange Commission (SEC) as an investment advisor, broker-dealer, or in any other capacity
- Is NOT a member of the Financial Industry Regulatory Authority (FINRA)
- Is NOT registered with any financial regulatory authority in any jurisdiction
- Does NOT hold any license to provide investment advice, financial advisory services, or securities recommendations
8. Consult Qualified Professionals
Before making any investment decision, users should consult with a qualified and licensed financial advisor, investment professional, or other appropriate professional who is registered with the relevant regulatory authority in their jurisdiction. Users should also consult qualified medical professionals regarding any health or pharmaceutical information presented on this Platform.
Investment in securities, including shares of pharmaceutical and biotechnology companies, involves significant risk, including the possible loss of the entire invested amount. Users should carefully consider their financial situation, investment objectives, and risk tolerance before making any investment.
9. Limitation of Liability
To the maximum extent permitted by applicable law, MarketsHost, its directors, officers, employees, agents, affiliates, and licensors shall not be liable for any direct, indirect, incidental, special, consequential, or punitive damages, including but not limited to:
- Financial losses arising from investment decisions made in reliance on information provided on this Platform
- Losses resulting from errors, inaccuracies, or omissions in the data or content
- Losses caused by AI-generated content that is incorrect, incomplete, or misleading
- Losses arising from delays in data updates or service interruptions
- Any other damages arising from the use of, or inability to use, this Platform
Users acknowledge that they use this Platform and its content entirely at their own risk.
10. US Biotech Focus
This Platform exclusively covers companies with drug pipelines regulated by the U.S. Food and Drug Administration (FDA). It does not cover Indian stocks, securities listed on NSE/BSE, or drug pipelines regulated by CDSCO or any non-US regulatory authority. The inclusion of US-listed securities on this Platform does not constitute an offer or solicitation in any jurisdiction where such offer or solicitation would be unlawful.
11. No Fiduciary Relationship
Use of this Platform does not create a fiduciary, advisory, agency, or professional relationship of any kind between MarketsHost and the user. MarketsHost owes no duty of care to any user of this Platform with respect to any investment or financial decision.
12. Changes to This Disclaimer
MarketsHost reserves the right to modify this Disclaimer at any time without prior notice. The "Last updated" date at the top of this page indicates the most recent revision. Continued use of the Platform after any changes constitutes acceptance of the updated Disclaimer.
By accessing and using the BioPharma Intelligence Hub, you acknowledge that you have read, understood, and agree to be bound by this Disclaimer in its entirety.